Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics | 4 | 2024 | 4 | 2.570 |
Why?
|
| Drug Interactions | 4 | 2024 | 26 | 1.730 |
Why?
|
| Perioperative Period | 3 | 2024 | 3 | 1.710 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 7 | 1.480 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2021 | 17 | 1.480 |
Why?
|
| Chronic Disease | 2 | 2021 | 135 | 1.400 |
Why?
|
| Electrocardiography | 3 | 2023 | 29 | 1.080 |
Why?
|
| Humans | 33 | 2024 | 4931 | 1.060 |
Why?
|
| Laryngoscopes | 2 | 2016 | 2 | 1.020 |
Why?
|
| Plant Preparations | 1 | 2024 | 1 | 0.890 |
Why?
|
| Herb-Drug Interactions | 1 | 2024 | 1 | 0.890 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 72 | 0.770 |
Why?
|
| Adult | 12 | 2023 | 1402 | 0.730 |
Why?
|
| Pain, Postoperative | 8 | 2017 | 19 | 0.680 |
Why?
|
| HIV Infections | 4 | 2016 | 167 | 0.640 |
Why?
|
| Laryngoscopy | 2 | 2016 | 2 | 0.640 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 9 | 0.630 |
Why?
|
| Pain Measurement | 5 | 2017 | 45 | 0.590 |
Why?
|
| Female | 17 | 2024 | 2964 | 0.530 |
Why?
|
| Postoperative Complications | 3 | 2016 | 82 | 0.520 |
Why?
|
| Video-Assisted Surgery | 1 | 2016 | 1 | 0.510 |
Why?
|
| Fiber Optic Technology | 1 | 2016 | 1 | 0.510 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 4 | 0.510 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 21 | 0.500 |
Why?
|
| Middle Aged | 14 | 2017 | 1544 | 0.480 |
Why?
|
| Betamethasone | 1 | 2015 | 4 | 0.480 |
Why?
|
| Steroids | 1 | 2015 | 8 | 0.480 |
Why?
|
| Low Back Pain | 1 | 2015 | 9 | 0.480 |
Why?
|
| Perioperative Care | 3 | 2024 | 5 | 0.470 |
Why?
|
| United States | 3 | 2024 | 764 | 0.470 |
Why?
|
| Male | 17 | 2024 | 2620 | 0.440 |
Why?
|
| Obesity | 1 | 2016 | 189 | 0.440 |
Why?
|
| Ambulatory Surgical Procedures | 4 | 2016 | 6 | 0.420 |
Why?
|
| Analgesics, Opioid | 6 | 2016 | 49 | 0.410 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 1 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 41 | 0.400 |
Why?
|
| Anesthesiology | 2 | 2024 | 3 | 0.400 |
Why?
|
| Aged | 8 | 2017 | 1188 | 0.390 |
Why?
|
| HIV-1 | 1 | 2012 | 17 | 0.390 |
Why?
|
| Clinical Competence | 2 | 2024 | 46 | 0.380 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2016 | 9 | 0.370 |
Why?
|
| Internship and Residency | 2 | 2024 | 47 | 0.370 |
Why?
|
| Prospective Studies | 6 | 2017 | 229 | 0.330 |
Why?
|
| Postoperative Nausea and Vomiting | 3 | 2020 | 3 | 0.290 |
Why?
|
| Pain Management | 3 | 2016 | 21 | 0.290 |
Why?
|
| Equipment Design | 3 | 2016 | 16 | 0.280 |
Why?
|
| Time Factors | 4 | 2016 | 245 | 0.270 |
Why?
|
| Anesthetics, Local | 2 | 2017 | 6 | 0.270 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 14 | 0.260 |
Why?
|
| Anxiety | 2 | 2017 | 32 | 0.260 |
Why?
|
| Patient Satisfaction | 4 | 2016 | 22 | 0.260 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 22 | 0.250 |
Why?
|
| Anesthesia, Conduction | 2 | 2016 | 3 | 0.250 |
Why?
|
| Young Adult | 2 | 2016 | 382 | 0.230 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 407 | 0.220 |
Why?
|
| Phytotherapy | 1 | 2024 | 5 | 0.220 |
Why?
|
| Faculty, Medical | 1 | 2024 | 16 | 0.220 |
Why?
|
| Dietary Supplements | 1 | 2024 | 38 | 0.210 |
Why?
|
| Heart | 1 | 2023 | 21 | 0.210 |
Why?
|
| Retrospective Studies | 5 | 2016 | 513 | 0.210 |
Why?
|
| Pneumothorax | 1 | 2022 | 2 | 0.200 |
Why?
|
| Educational Measurement | 1 | 2020 | 17 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2015 | 402 | 0.170 |
Why?
|
| Anesthetics, Intravenous | 2 | 2016 | 2 | 0.160 |
Why?
|
| Midazolam | 2 | 2016 | 3 | 0.160 |
Why?
|
| Adenosine | 2 | 2017 | 8 | 0.160 |
Why?
|
| Dexamethasone | 2 | 2017 | 24 | 0.160 |
Why?
|
| Double-Blind Method | 6 | 2017 | 81 | 0.160 |
Why?
|
| Anesthesia | 2 | 2016 | 7 | 0.150 |
Why?
|
| Intercostal Nerves | 1 | 2017 | 1 | 0.140 |
Why?
|
| Autonomic Nerve Block | 1 | 2017 | 2 | 0.140 |
Why?
|
| Analgesia, Epidural | 1 | 2017 | 4 | 0.140 |
Why?
|
| Interleukin-4 | 1 | 2017 | 7 | 0.140 |
Why?
|
| Hippocampus | 1 | 2017 | 15 | 0.140 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 14 | 0.140 |
Why?
|
| Facial Expression | 1 | 2017 | 1 | 0.140 |
Why?
|
| Manifest Anxiety Scale | 1 | 2017 | 1 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2017 | 4 | 0.140 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 12 | 0.130 |
Why?
|
| Analgesia | 1 | 2016 | 16 | 0.130 |
Why?
|
| Preanesthetic Medication | 1 | 2016 | 1 | 0.130 |
Why?
|
| Mental Recall | 1 | 2016 | 1 | 0.130 |
Why?
|
| Propofol | 1 | 2016 | 3 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 7 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2016 | 1 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2016 | 4 | 0.130 |
Why?
|
| Immobilization | 1 | 2016 | 4 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2016 | 10 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 16 | 0.130 |
Why?
|
| Ritonavir | 1 | 2016 | 1 | 0.130 |
Why?
|
| HIV Protease Inhibitors | 1 | 2016 | 2 | 0.130 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 10 | 0.130 |
Why?
|
| Coronary Stenosis | 1 | 2017 | 37 | 0.130 |
Why?
|
| Inflammation | 1 | 2017 | 122 | 0.130 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 5 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2015 | 4 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2016 | 32 | 0.120 |
Why?
|
| Anesthetics, Dissociative | 1 | 2015 | 1 | 0.120 |
Why?
|
| Heart, Artificial | 1 | 2015 | 1 | 0.120 |
Why?
|
| Injections, Epidural | 1 | 2015 | 1 | 0.120 |
Why?
|
| Sternotomy | 1 | 2015 | 1 | 0.120 |
Why?
|
| Ketamine | 1 | 2015 | 2 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 126 | 0.120 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
| Arthroplasty | 1 | 2014 | 1 | 0.120 |
Why?
|
| Prescription Drug Misuse | 1 | 2014 | 1 | 0.120 |
Why?
|
| Prescription Drug Diversion | 1 | 2014 | 1 | 0.120 |
Why?
|
| Emergency Nursing | 1 | 2014 | 2 | 0.120 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 3 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 4 | 0.120 |
Why?
|
| Fentanyl | 1 | 2014 | 7 | 0.120 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 1 | 0.120 |
Why?
|
| Spinal Puncture | 1 | 2014 | 1 | 0.120 |
Why?
|
| Myelography | 1 | 2014 | 2 | 0.120 |
Why?
|
| Spinal Diseases | 1 | 2014 | 3 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2014 | 12 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 11 | 0.110 |
Why?
|
| Nursing Staff, Hospital | 1 | 2014 | 8 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 17 | 0.110 |
Why?
|
| Hypercapnia | 1 | 2014 | 1 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 17 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2014 | 7 | 0.110 |
Why?
|
| Adolescent | 1 | 2016 | 569 | 0.110 |
Why?
|
| Cough | 2 | 2014 | 3 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 34 | 0.110 |
Why?
|
| Qualitative Research | 2 | 2024 | 44 | 0.100 |
Why?
|
| Viral Load | 1 | 2012 | 11 | 0.100 |
Why?
|
| Acupressure | 1 | 2012 | 1 | 0.100 |
Why?
|
| Disposable Equipment | 1 | 2012 | 2 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2012 | 15 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 1 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 5 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2011 | 7 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 7 | 0.090 |
Why?
|
| Animals | 4 | 2017 | 1369 | 0.090 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2010 | 1 | 0.090 |
Why?
|
| Ibuprofen | 1 | 2010 | 3 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2010 | 8 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2010 | 11 | 0.090 |
Why?
|
| Activities of Daily Living | 3 | 2020 | 17 | 0.090 |
Why?
|
| Health Personnel | 2 | 2022 | 40 | 0.080 |
Why?
|
| Anesthesia Recovery Period | 1 | 2009 | 1 | 0.080 |
Why?
|
| Isoflurane | 1 | 2009 | 1 | 0.080 |
Why?
|
| Methyl Ethers | 1 | 2009 | 1 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 1 | 0.080 |
Why?
|
| Anesthesia, Inhalation | 1 | 2009 | 3 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2016 | 179 | 0.070 |
Why?
|
| Antiemetics | 2 | 2020 | 3 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 152 | 0.060 |
Why?
|
| Dogs | 2 | 2017 | 16 | 0.060 |
Why?
|
| Vasodilator Agents | 2 | 2017 | 6 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 83 | 0.060 |
Why?
|
| Competency-Based Education | 1 | 2024 | 3 | 0.060 |
Why?
|
| Feedback | 1 | 2024 | 12 | 0.060 |
Why?
|
| Decision Making | 1 | 2024 | 17 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 21 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 149 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 65 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 35 | 0.050 |
Why?
|
| Aftercare | 1 | 2020 | 6 | 0.040 |
Why?
|
| Checklist | 1 | 2020 | 2 | 0.040 |
Why?
|
| Los Angeles | 2 | 2012 | 244 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 6 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 19 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 7 | 0.030 |
Why?
|
| Microglia | 1 | 2017 | 3 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 2 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 58 | 0.030 |
Why?
|
| Exercise Test | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 66 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 176 | 0.030 |
Why?
|
| Pain, Procedural | 1 | 2016 | 1 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 2 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Aging | 1 | 2017 | 92 | 0.030 |
Why?
|
| Hospitals | 1 | 2016 | 14 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2016 | 4 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 15 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 224 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 21 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 2 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 2 | 0.030 |
Why?
|
| Professional Misconduct | 1 | 2014 | 2 | 0.030 |
Why?
|
| Substance Abuse Detection | 1 | 2014 | 2 | 0.030 |
Why?
|
| Movement | 1 | 2014 | 4 | 0.030 |
Why?
|
| Spinal Cord Compression | 1 | 2014 | 1 | 0.030 |
Why?
|
| Myocardium | 1 | 2014 | 19 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 70 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 45 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 13 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2014 | 5 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 98 | 0.030 |
Why?
|
| Recurrence | 1 | 2014 | 25 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2014 | 6 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 33 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 40 | 0.030 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 8 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 93 | 0.030 |
Why?
|
| Oximetry | 1 | 2014 | 1 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 358 | 0.030 |
Why?
|
| Risk Factors | 1 | 2014 | 593 | 0.020 |
Why?
|
| Ondansetron | 1 | 2012 | 1 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 2012 | 2 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 29 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2011 | 2 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2011 | 4 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 13 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 6 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 16 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2011 | 13 | 0.020 |
Why?
|
| Celecoxib | 1 | 2010 | 1 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2010 | 4 | 0.020 |
Why?
|
| Italy | 1 | 2010 | 2 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 5 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 36 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 196 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 555 | 0.020 |
Why?
|